HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Candan Gurses Selected Research

Double cortex

12/2017Investigation of anti-neuronal antibodies in status epilepticus of unknown etiology: a prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Candan Gurses Research Topics

Disease

9Temporal Lobe Epilepsy
10/2020 - 10/2013
9Seizures (Absence Seizure)
09/2018 - 02/2002
8Epilepsy (Aura)
07/2018 - 12/2012
5Hippocampal Sclerosis
10/2016 - 10/2013
4Status Epilepticus (Complex Partial Status Epilepticus)
12/2017 - 02/2002
3Subacute Sclerosing Panencephalitis (SSPE)
01/2021 - 10/2014
3Drug Resistant Epilepsy
10/2016 - 04/2014
2Autoimmune Diseases of the Nervous System
12/2017 - 03/2016
2Partial Epilepsies (Epilepsy, Partial)
10/2016 - 03/2014
2Malformations of Cortical Development
11/2010 - 07/2009
1Encephalitis (Encephalitis, Rasmussen)
07/2018
1Glioma (Gliomas)
01/2018
1Phenylketonurias (Phenylketonuria)
01/2018
1Neoplasms (Cancer)
12/2017
1Double cortex
12/2017
1Essential Tremor (Essential Tremors)
12/2016
1Tremor (Tremors)
12/2016
1Juvenile Myoclonic Epilepsy
12/2016
1Psychotic Disorders (Schizoaffective Disorder)
03/2016
1Epilepsia Partialis Continua
08/2015
1Generalized Epilepsy
12/2012
1Edema (Dropsy)
11/2010
1Hyperekplexia
07/2010

Drug/Important Bio-Agent (IBA)

5AutoantibodiesIBA
07/2018 - 03/2014
3Anticonvulsants (Antiepileptic Drugs)IBA
09/2018 - 11/2010
3AntibodiesIBA
07/2018 - 03/2014
3Levetiracetam (Keppra)FDA LinkGeneric
08/2015 - 07/2009
3Pentylenetetrazole (Metrazol)IBA
07/2009 - 02/2002
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2018 - 03/2014
2Pharmaceutical PreparationsIBA
01/2018 - 10/2016
2N-Methylaspartate (NMDA)IBA
12/2017 - 03/2014
2Mitochondrial DNA (mtDNA)IBA
04/2014 - 10/2013
2Coloring Agents (Dyes)IBA
05/2006 - 02/2002
1Interleukin-2 (IL2)IBA
01/2021
1CytokinesIBA
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2021
1indolepropanol phosphate (IPP)IBA
10/2020
1GoldIBA
09/2020
1LacosamideFDA Link
09/2020
1Natalizumab (Tysabri)FDA Link
09/2018
1Amino AcidsFDA Link
01/2018
1A 113IBA
01/2018
1gamma-Aminobutyric Acid (GABA)IBA
12/2017
1Valproic Acid (Depakote)FDA LinkGeneric
12/2016
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2016
1erucylphosphocholineIBA
08/2015
1NK Cell Lectin-Like Receptor Subfamily CIBA
12/2014
1Granzymes (Granzyme)IBA
10/2014
1Glycine Receptors (Glycine Receptor)IBA
03/2014
1Proteins (Proteins, Gene)FDA Link
03/2014
1Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
03/2014
1Immunoglobulin E (IgE)IBA
12/2012
1Glial Fibrillary Acidic ProteinIBA
11/2010
1OccludinIBA
11/2010
1DNA (Deoxyribonucleic Acid)IBA
07/2010
1Ligand-Gated Ion ChannelsIBA
07/2010
1AlbuminsIBA
05/2006
1Evans Blue (Blue, Evans)FDA Link
05/2006
1Interleukin-6 (Interleukin 6)IBA
05/2006
1LipopolysaccharidesIBA
05/2006
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2002
1Glucose (Dextrose)FDA LinkGeneric
02/2002
1Vitamin EFDA LinkGeneric
02/2002
1CatalaseIBA
02/2002
1alpha-TocopherolFDA Link
02/2002

Therapy/Procedure

1Electrodes (Electrode)
01/2018
1Aftercare (After-Treatment)
12/2016
1Transcranial Direct Current Stimulation
10/2016
1Therapeutics
04/2013
1Induced Hyperthermia (Thermotherapy)
11/2010